深渊 发表于 2025-3-25 07:22:28

http://reply.papertrans.cn/2/116/11595/11595-21.png

Hyperlipidemia 发表于 2025-3-25 10:04:06

http://reply.papertrans.cn/2/116/11595/11595-22.png

Legend 发表于 2025-3-25 15:00:48

Submitted on: 31 December 2003.
Revised on: 03 March 2004.
Accepted on: 13 April 2004.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

明智的人 发表于 2025-3-25 18:13:51

http://reply.papertrans.cn/2/116/11595/11595-24.png

DUST 发表于 2025-3-25 22:37:31

http://reply.papertrans.cn/2/116/11595/11595-25.png

Constrain 发表于 2025-3-26 01:46:02

http://reply.papertrans.cn/2/116/11595/11595-26.png

藕床生厌倦 发表于 2025-3-26 07:21:39

http://reply.papertrans.cn/2/116/11595/11595-27.png

enchant 发表于 2025-3-26 10:42:23

Submitted on: 17 October 2023.
Revised on: 07 February 2024.
Accepted on: 19 February 2024.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

NEEDY 发表于 2025-3-26 15:35:52

Submitted on: 21 November 2013.
Revised on: 10 March 2014.
Accepted on: 04 May 2014.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Afflict 发表于 2025-3-26 18:39:12

Submitted on: 20 June 2003.
Revised on: 01 October 2003.
Accepted on: 29 October 2003.

___________________HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
页: 1 2 [3] 4
查看完整版本: SCIE期刊HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL 2024/2025影响因子:1.805 (HUM PSYCHOPHARM CLIN) (0885-6222). (PSYCH